PDF
Full
Outline
To analyze the relationship between cardiovascular-metabolic complications andbasic activity of daily living(BADL) and instrumental activities of daily living (IADL) in Chinese middle-aged and elderly individuals, and to explore the factors influencing different types of ADLs in this demographic with cardiovascular-metabolic complications.
The effects of cardiovascular-metabolic co-morbidities on ADLs among middle-aged and elderly individuals were investigated using the χ2 test and logistic regression model in a sample of individuals aged 45 and older from the 2020 China Health and Elderly Care Tracking Survey.A randomized forest prediction model was developed to investigate the influencing factors of different types of activities of daily living in middle-aged and elderly people with cardiovascular-metabolic co-morbidities, and to predict the importance of each influencing factor.
Among China’s middle-aged and elderly population, 19.75% had at least one cardiovascular metabolic disease (CMD), and 4.18% had cardiovascular metabolic co-morbidities (CMM). The prevalence of BADL impairment was 15.90%, and that of IADL impairment was 17.32%.After adjusting for confounding factors like age and sex, middle-aged and older adults with cardiovascular metabolic co-morbidities had a higher risk of developing impaired ADLs compared to their counterparts without these co-morbidities (BADL: OR=1.662, 95% CI: 1.246-2.216; IADL: OR=2.186, 95% CI: 1.663-2.874).Age, depression, pain distress, life satisfaction, literacy, and participation in social activities were predictive of impaired BADL and IADL in older adults with multiple cardiovascular-metabolic co-morbidities, with good predictive modeling (BADL: AUC=0.804; IADL: AUC=0.761).
Middle-aged and older adults with multiple cardiovascular-metabolic co-morbidities are more likely to experience impairments in ADLs. Healthcare providers should consider the specific conditions and risk factors of this demographic and develop personalized, multidimensional intervention programs focusing on mental health, pain and chronic disease management, and life satisfaction enhancement to prevent ADL decline in those with cardiovascular-metabolic co-morbidities.
PDF
68
31
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62199257
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
